Home / Treatments / Incontinence Supplies

Incontinence Supplies denials: what the review data shows

Independent reviewers have decided 15 published cases where an insurer denied Incontinence Supplies — and they overturned the insurer 66.7% of the time. A denial for Incontinence Supplies is a starting position, not a final answer.

Published decisions
15
2001–2026
Overturned
66.7%
10 denials reversed

Conditions behind incontinence supplies denials

What insurers denied — and how those fights ended.
CategoryDecisionsOverturned
Autistic Disorder5
80%
Incontinence5
40%
Typical time to a decision
15 days
Most land between 11 and 19 days
Handled as urgent
13.3%
Expedited when a delay would cause harm
What the reviewers wrote
Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: A patient’s parent has requested authorization and coverage for incontinence supplies including large/x-large Pull-Ups. In this case, the patient presents with moderate to severe autism and developmental delays. As noted in the medical literature, incontinence supplies may be considered medically necessary if they are required to manage or treat a medical condition. Per a review of the literature, bladder and bowel incontinence is common in pediatric patients with autism. There are many challenges to proper toilet training in this patient population. Overall, the efficacy of treatment varies depending on patient characteristics such as age and severity of the underlying developmental disability. In this case, the patient has incontinence.
Medical Necessity · 2025 · IMR MN25-43764
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: A patient’s parent has requested authorization and coverage for incontinence supplies including pediatric-sized disposable diapers, underpads, wipes, and gloves. On review of the current medical literature, bladder and bowel incontinence are commonly associated with pediatric patients with global developmental delays. There are many challenges to proper toilet training in this patient population. Generally, behavioral approaches are used with varying efficacy depending on patient characteristics such as age and severity of the underlying developmental disability. In this case, the patient has incontinence due to Angelman syndrome, which is caused by chromosomal deletion, and characterized by severe developmental delays.
Medical Necessity · 2025 · IMR MN25-43727

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for wipes.Researchers state that risk factors for development of incontinence-associated dermatitis include compromised skin (e.g., due to aging, steroid use or local trauma/friction), immobility, decreased cognitive awareness, inability to perform personal hygiene, pyrexia, and poor nutritional status. Due to a lack of high quality experimental literature, prevention and treatment of incontinence-associated dermatitis is largely guided by expert opinion and focused on addressing the incontinence itself when feasible, timely clean up following incontinent episodes, and applying skin protectants, such as barrier creams.
Medical Necessity · 2021 · IMR MN21-35120
Nature of Statutory Criteria/Case Summary: The patient’s parent has requested authorization and coverage for Huggies brand incontinence diapers. Daytime urinary incontinence is common in the pediatric population and affects approximately 7-10% of children aged five to thirteen years. Risk factors for incontinence can be genetic, demographic, environmental, behavioral, or physical. In this case, the patient is 17 months old, and is not yet expected to be continent. As part of routine infant and toddler care, diapers are not medically indicated for the patient at this time.
Medical Necessity · 2020 · IMR MN20-33695

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California outcomes — every state runs an equivalent external review, but the rates here are California’s. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.

How to use this in your appeal

These are outcomes from California’s external review program — an independent physician panel that binds the insurer. Every state has an equivalent process, and internal appeals succeed even more often. Cite the outcome record for Incontinence Supplieswhen you appeal: reviewers routinely find that denials like yours didn’t hold up.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Denied Incontinence Supplies? 66.7% got it reversed.

Explain my denial — freeStart my appeal · $39